
Accomplished professional with expertise in strategic leadership and stakeholder management, driving organisational agility and sales growth. Proven track record in budget control and P&L management, ensuring financial health and sustainability. Adept at monitoring key performance indicators to optimise product lifecycle management. Committed to fostering leadership and motivation within teams to achieve business objectives.
Business Unit Head for Rare Diseases. P&L responsible. Strategic and Operational Leader for the Rare Blood Disorder, Rare Endocrine Disorders, Haemoglobinopathies and Women’s Health franchises, striving for sustainable growth and improving patient impact. Leading cross functional teams of sales, marketing, and market access.